Friday, 12 October 2018

J&J's Stelara succeeds in chronic bowel disease study

Johnson & Johnson said on Tuesday its blockbuster drug Stelara was found to be effective in treating a chronic bowel disease in a late-stage trial.


from Reuters: Science News https://ift.tt/2NwMMr7
//

Related Posts:

0 comments:

Post a Comment